Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Predictive Oncology Inc.

    NASDAQ: POAI · Real-Time Price · USD
    0.94
    -0.02 (-2.03%)
    At close: Jun 17, 2025, 10:38 AM

    Predictive Oncology Statistics

    Share Statistics

    Predictive Oncology has 8.93M shares outstanding. The number of shares has increased by 75.76% in one year.

    Shares Outstanding

    n/a
    		 8.93M

    Shares Change (YoY)

    n/a
    		 75.76%

    Shares Change (QoQ)

    n/a
    		 8.14%

    Owned by Institutions (%)

    n/a
    		 3.77%

    Shares Floating

    n/a
    		 8.8M

    Failed to Deliver (FTD) Shares

    n/a
    		 17,061

    FTD / Avg. Volume

    n/a
    		 0.63%

    Short Selling Information

    The latest short interest is 189.84K, so 2.13% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 189.84K

    Short % of Shares Out

    n/a
    		 2.13%

    Short % of Float

    n/a
    		 2.15%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -0.37 and the forward PE ratio is 11.88. Predictive Oncology's PEG ratio is 0.01.

    PE Ratio

    n/a
    		 -0.37

    Forward PE

    n/a
    		 11.88

    PS Ratio

    n/a
    		 2.75

    Forward PS

    n/a
    		 0.3

    PB Ratio

    n/a
    		 -22.07

    P/FCF Ratio

    n/a
    		 -0.41

    PEG Ratio

    n/a
    		 0.01
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Predictive Oncology.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 0.62, with a Debt / Equity ratio of -10.52.

    Current Ratio

    n/a
    		 0.62

    Quick Ratio

    n/a
    		 0.51

    Debt / Equity

    n/a
    		 -10.52

    Debt / EBITDA

    n/a
    		 -0.21

    Debt / FCF

    n/a
    		 -0.19

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $70,600.74

    Profits Per Employee

    n/a
    		 $-530,489.61

    Employee Count

    n/a
    		 23

    Asset Turnover

    n/a
    		 0.33

    Inventory Turnover

    n/a
    		 2.14

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -17.95% in the last 52 weeks. The beta is 1.2, so Predictive Oncology's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.2

    52-Week Price Change

    n/a
    		 -17.95%

    50-Day Moving Average

    n/a
    		 1.01

    200-Day Moving Average

    n/a
    		 1.02

    Relative Strength Index (RSI)

    n/a
    		 46.14

    Average Volume (20 Days)

    n/a
    		 2,707,995

    Income Statement

    In the last 12 months, Predictive Oncology had revenue of 1.62M and earned -12.2M in profits. Earnings per share was -2.32.

    Revenue

    n/a
    		 1.62M

    Gross Profit

    n/a
    		 797.68K

    Operating Income

    n/a
    		 -10.94M

    Net Income

    n/a
    		 -12.2M

    EBITDA

    n/a
    		 -10.16M

    EBIT

    n/a
    		 -10.94M

    Earnings Per Share (EPS)

    n/a
    		 -2.32
    Full Income Statement

    Balance Sheet

    The company has 734.67K in cash and 2.13M in debt, giving a net cash position of -1.4M.

    Cash & Cash Equivalents

    n/a
    		 734.67K

    Total Debt

    n/a
    		 2.13M

    Net Cash

    n/a
    		 -1.4M

    Retained Earnings

    n/a
    		 -180.43M

    Total Assets

    n/a
    		 5.87M

    Working Capital

    n/a
    		 -1.12M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -10.97M and capital expenditures -9.51K, giving a free cash flow of -10.98M.

    Operating Cash Flow

    n/a
    		 -10.97M

    Capital Expenditures

    n/a
    		 -9.51K

    Free Cash Flow

    n/a
    		 -10.98M

    FCF Per Share

    n/a
    		 -2.01
    Full Cash Flow Statement

    Margins

    Gross margin is 49.12%, with operating and profit margins of -673.69% and -751.39%.

    Gross Margin

    n/a
    		 49.12%

    Operating Margin

    n/a
    		 -673.69%

    Pretax Margin

    n/a
    		 -668.81%

    Profit Margin

    n/a
    		 -751.39%

    EBITDA Margin

    n/a
    		 -625.97%

    EBIT Margin

    n/a
    		 -673.69%

    FCF Margin

    n/a
    		 -676.44%

    Dividends & Yields

    POAI does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for POAI.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Apr 24, 2023. It was a backward split with a ratio of 1:20.

    Last Split Date

    n/a
    		 Apr 24, 2023

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:20

    Scores

    Altman Z-Score

    n/a
    		 -48.39

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist